A piercing, flexible and simple approach to the US safety needle market
This article was originally published in Clinica
Specialized Health Products International (SHPI) is one of the growing number of small product development companies seeking to capitalise on the increasing importance of safety needle products in the US. Imogen Daulby asked the company how it would survive in such a fiercely competitive area.
You may also be interested in...
New medicines under evaluation at the European Medicines Agency.
Discussions on the shape of health care have moved from “reimagining” to the next stage: building and executing on the vision. That is the thrust of EY’s NextWave Report: New Horizons 2019. Additionally, for medtechs seeking business continuum, “duality” is now a preoccupying thought.
The idea that public corporations have obligations that extend beyond the fiduciary responsibility to shareholders will be the dominant measure of responsible business behavior in the coming decade. Uncertainty about the extent of these commitments – commonly referenced as the environmental, social and governance (ESG) agenda – has produced equally variable responses from companies in the health care business.